Literature DB >> 19128005

Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model.

Hyun A Lee1, Teresa L Leavens, Sharon E Mason, Nancy A Monteiro-Riviere, Jim E Riviere.   

Abstract

A physiologically based pharmacokinetic model with partition coefficients estimated from quantum dot (QD) 705 biodistribution was compared with the biodistribution of other QDs in mice and rats to determine the model's predictive ability across QD types, species, and exposure routes. The model predicted the experimentally observed persistence of QDs in tissues but not early time profiles or different QD biodistribution. Therefore, more complex models will be needed to better predict QD biodistribution in vivo.

Entities:  

Mesh:

Year:  2009        PMID: 19128005     DOI: 10.1021/nl803481q

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  16 in total

1.  An index for characterization of nanomaterials in biological systems.

Authors:  Xin-Rui Xia; Nancy A Monteiro-Riviere; Jim E Riviere
Journal:  Nat Nanotechnol       Date:  2010-08-15       Impact factor: 39.213

Review 2.  Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.

Authors:  Min Li; Peng Zou; Katherine Tyner; Sau Lee
Journal:  AAPS J       Date:  2016-11-10       Impact factor: 4.009

3.  Aqueous, protein-driven synthesis of transition metal-doped ZnS immuno-quantum dots.

Authors:  Weibin Zhou; François Baneyx
Journal:  ACS Nano       Date:  2011-09-28       Impact factor: 15.881

Review 4.  Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Authors:  Darren Michael Moss; Marco Siccardi
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

5.  In vitro biodistribution of silver nanoparticles in isolated perfused porcine skin flaps.

Authors:  Teresa L Leavens; Nancy A Monteiro-Riviere; Alfred O Inman; James D Brooks; Steven J Oldenburg; Jim E Riviere
Journal:  J Appl Toxicol       Date:  2012-07-04       Impact factor: 3.446

6.  Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.

Authors:  Zhoumeng Lin; Wei-Chun Chou; Yi-Hsien Cheng; Chunla He; Nancy A Monteiro-Riviere; Jim E Riviere
Journal:  Int J Nanomedicine       Date:  2022-03-24

7.  Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content.

Authors:  Mingguang Li; Zoi Panagi; Konstantinos Avgoustakis; Joshua Reineke
Journal:  Int J Nanomedicine       Date:  2012-03-07

8.  Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles.

Authors:  Ulrika Carlander; Dingsheng Li; Olivier Jolliet; Claude Emond; Gunnar Johanson
Journal:  Int J Nanomedicine       Date:  2016-02-11

9.  A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles.

Authors:  Gerald Bachler; Natalie von Goetz; Konrad Hungerbühler
Journal:  Int J Nanomedicine       Date:  2013-09-02

10.  In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats.

Authors:  Dingsheng Li; Masako Morishita; James G Wagner; Mohammad Fatouraie; Margaret Wooldridge; W Ethan Eagle; James Barres; Ulrika Carlander; Claude Emond; Olivier Jolliet
Journal:  Part Fibre Toxicol       Date:  2016-08-20       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.